National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


20 to 75


Other


27MD02
NCT00154713

Last Modified: 6/12/2008     First Published: 3/18/2008  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


DUMC-PRO00003877
Pro00003877, DUMC-8108-07-1R1, NCT00639639

Last Modified: 11/27/2007     First Published: 8/18/2006  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


UMN-2003LS014
UMN-0302M41542, UMN-MT2003-03, NCT00369291


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Biomarker/Laboratory analysis, Treatment


Active


18 to 55


NCRR


NCRR-M01RR00400-0626
M01RR00400, NCT00000105

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov